This important result supports our initial finding from the established BC cell lines of triple-negative origin (Figure 1A) and also suggests that WAVE3 expression levels in the blood of BC patients can be used as biomarker for the identification of BC patients with Triple-Negative tumors. The gene discussed is WASF3; the disease is breast cancer.